UNSPSC 51282113: Propicillin

This classification denotes a penicillin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8X1R260V33. European Medicines Agency schedules Propicillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10106MIG. Propicillin generally arises in the molecular formula C18H22N2O5S. The term PROPICILLIN is an International Non-Proprietary Name or INN. PROPICILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule propicillin under HS 29411090 and SITC 54131. As of Q4 2014, PROPICILLIN remains the US FDA Preferred Term for this commodity. Propicillin bears US NLM identifiers UMLS ID C0072176 and NCI Concept Code C66483. SMILES: S1C2N(C(C1(C)C)C(=O)O)C(=O)C2NC(=O)C(OC1CCCCC1)CC.

UNSPSC 51282113 Propicillin, a Commodity code, shows minimal relevant recent activity in state and local procurement. The code's nominal scope—propicillin, a narrow-spectrum beta-lactam antibiotic—does not align with the actual work being solicited under this code designation. The four most recent state and local opportunities tagged to this code involve naloxone and drug deactivation systems, multi-source generic pharmaceuticals and over-the-counter products, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription fulfillment programs. These solicitations represent pharmaceutical procurement, emergency medical supplies, and pharmacy benefit management infrastructure—none of which involve propicillin specifically. The mismatch suggests either systematic tagging errors in the underlying procurement databases or that the code is used as a catch-all placeholder for pharmaceutical and medical product purchases when more precise commodity codes are unavailable.

The geographic spread of recent activity spans Florida (Seminole County), Texas (Texas Health and Human Services Commission), Minnesota (MMCAP cooperative covering multiple states including Oregon), and Florida again (City of Tampa). Issuing bodies include county health departments, state health and human services commissions, municipal fire departments, and multi-state cooperative purchasing organizations. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems due July 26, 2023, the City of Tampa's ITB for medical and first aid supplies with a response deadline of March 13, 2026 and an estimated contract value of $700,000, and Minnesota's MMCAP RFP for generic pharmaceuticals and OTC products due March 26, 2026. The Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescriptions, posted April 3, 2026, signals emerging state-level interest in alternative pharmacy contracting models. Given the absence of propicillin-specific procurement signals, this code warrants a watch status rather than active pursuit unless your firm specializes in broader pharmaceutical distribution or emergency medical supplies capable of fitting the actual solicitation scope.